Subscribe
shutterstock_728418352_casimiropt
casimiropt / Shutterstock.com
6 August 2019Big PharmaSaman Javed

Allergan to pay $2.7m to settle antitrust suit over Asacol

A subsidiary of Irish pharmaceutical company Allergan is to pay a combined total of $2.7 million to three organisations that were part of an antitrust class against the drugmaker.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Generics
Actavis and Zydus settle Asacol patent dispute
10 June 2014   Irish-based drug manufacturer Actavis has settled its patent dispute with Zydus Pharmaceuticals.
Americas
Allergan pays $750m to resolve antitrust litigation
29 October 2019   Allergan has reached a $750 million deal to resolve antitrust litigation brought against its subsidiary Forest Laboratories over Alzheimer’s drug Namenda.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Generics
Actavis and Zydus settle Asacol patent dispute
10 June 2014   Irish-based drug manufacturer Actavis has settled its patent dispute with Zydus Pharmaceuticals.
Americas
Allergan pays $750m to resolve antitrust litigation
29 October 2019   Allergan has reached a $750 million deal to resolve antitrust litigation brought against its subsidiary Forest Laboratories over Alzheimer’s drug Namenda.

More on this story

Generics
Actavis and Zydus settle Asacol patent dispute
10 June 2014   Irish-based drug manufacturer Actavis has settled its patent dispute with Zydus Pharmaceuticals.
Americas
Allergan pays $750m to resolve antitrust litigation
29 October 2019   Allergan has reached a $750 million deal to resolve antitrust litigation brought against its subsidiary Forest Laboratories over Alzheimer’s drug Namenda.

More features

Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York
UPC deals further blow to Dexcom in glucose monitor dispute with Abbott
‘A marathon and a sprint at the same time’: How we won $452m damages